Carbomycin is a complex mixture containing carbomycin A with a small portion of carbomycin B. Carbomycin is produced by Streptomyces halstedii and acts as an antibiotic. The drug was approved by FDA under the name Magna-terramycin (in combination with oxytetracycline) for the treatment of bacterial chronic respiratory diseases in chickens. Carbomycin exerts its antibacterial action by binding within the large ribosomal subunit and thus inhibiting the protein synthesis in bacterias.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5845078
Curator's Comment: Now known as Pfizer.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2363135 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6179465 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | MAGNA-TERRAMYCIN Approved UseAs an aid in the prevention and treatment of complicated chronic respiratory disease (air-sac infection) caused by Mycoplasma gallisepticum and secondary bacterial organisms associated with chronic respiratory disease such as E. coli. |
PubMed
Title | Date | PubMed |
---|---|---|
The treatment of infectious diseases: advances in the use of antimicrobial drugs. | 1953 Oct |
|
The dried disc technique with bacitracin, carbomycin, erythromycin, polymyxin B, and tetracycline. | 1955 May |
|
Bacteriophage types and antibiotic sensitivity of staphylococci from bovine milk and human nares. | 1965 Sep |
|
Mutant of Staphylococcus aureus with lincomycin- and carbomycin-inducible resistance to erythromycin. | 1974 May |
|
Cytoplasmic inheritance of erythromycin resistance in human cells. | 1979 Sep |
|
Erythromycin, carbomycin, and spiramycin inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes. | 1982 May |
|
Nucleotide sequence analysis of the carbomycin biosynthetic genes including the 3-O-acyltransferase gene from Streptomyces thermotolerans. | 1995 Apr |
|
Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library. | 2014 Jul |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.law.cornell.edu/cfr/text/21/520.1660a
1.0 gram of oxytetracycline as oxytetracycline hydrochloride and 1.0 gram carbomycin as carbomycin base per gallon of drinking water.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26038747
Carbomycin was tested against B. burgdorferi and the MIC value was determined to be less than 0.25 ug/ml.
Substance Class |
Mixture
Created
by
admin
on
Edited
Sat Dec 16 01:46:37 GMT 2023
by
admin
on
Sat Dec 16 01:46:37 GMT 2023
|
Record UNII |
3952621T3O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 520.1660A
Created by
admin on Sat Dec 16 01:46:37 GMT 2023 , Edited by admin on Sat Dec 16 01:46:37 GMT 2023
|
||
|
CFR |
21 CFR 556.110
Created by
admin on Sat Dec 16 01:46:37 GMT 2023 , Edited by admin on Sat Dec 16 01:46:37 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C166659
Created by
admin on Sat Dec 16 01:46:37 GMT 2023 , Edited by admin on Sat Dec 16 01:46:37 GMT 2023
|
PRIMARY | |||
|
300000036856
Created by
admin on Sat Dec 16 01:46:37 GMT 2023 , Edited by admin on Sat Dec 16 01:46:37 GMT 2023
|
PRIMARY | |||
|
3952621T3O
Created by
admin on Sat Dec 16 01:46:37 GMT 2023 , Edited by admin on Sat Dec 16 01:46:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104385
Created by
admin on Sat Dec 16 01:46:37 GMT 2023 , Edited by admin on Sat Dec 16 01:46:37 GMT 2023
|
PRIMARY | |||
|
CARBOMYCIN
Created by
admin on Sat Dec 16 01:46:37 GMT 2023 , Edited by admin on Sat Dec 16 01:46:37 GMT 2023
|
PRIMARY | |||
|
DB11383
Created by
admin on Sat Dec 16 01:46:37 GMT 2023 , Edited by admin on Sat Dec 16 01:46:37 GMT 2023
|
PRIMARY | |||
|
202
Created by
admin on Sat Dec 16 01:46:37 GMT 2023 , Edited by admin on Sat Dec 16 01:46:37 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |